Headlines in Reproductive Medicine
May 15, 2013
Consumers should not buy sexual enhancement supplements, either online or in stores, because the products may contain undisclosed drugs that could cause serious harm, medical experts say.
Headlines in Reproductive Medicine
May 14, 2013
Over millions of years, evolution by natural selection has produced adaptations in humans: biological and psychological traits that improved human survival and reproduction in ancestral environments. For example, ripe fruit was an infrequent but calorically rich part of the human ancestral diet. We therefore have a sweet tooth that rewards us when we eat ripe fruit.
Headlines in Reproductive Medicine
May 08, 2013
Wake Forest University researchers have conducted early, pre-clinical work that they say supports further research on the use of spermatogonial stem cell (SSC) transplantation as a potential treatment for male infertility.
Headlines in Reproductive Medicine
May 07, 2013
Male infertility may account for up to 50% of a couple’s inability to conceive, with multiple factors potentially contributing to this problem, a speaker said here.
Press Releases
October 23, 2012
At the 68th Annual Meeting of the American Society for Reproductive Medicine, doctors from Kansas City Medical Center reported results of a survey showing differences between men’s and women’s beliefs and attitudes toward a reversible male contraceptive (RMC).
Press Releases
October 23, 2012
Research presented at the 68th Annual Meeting of the American Society for Reproductive Medicine showed the important role nutrition plays in reproductive health. The studies pointed to the impact of diet on sperm quality and on IVF success rates.
Press Releases
September 19, 2012
Some of the many fascinating research topics to be presented at the meeting include male and female fertility preservation, robotics in surgery, stem cell research, sexuality, nutrition and reproductive health, innovations in genetic screening and epigenetics. Contraception Day, Menopause Day and Surgery Day will provide a special focus on these areas while plenary lectures, seminars, symposia and workshops offer a variety of ways to learn about the latest advances in all aspects of the field.
CDC Announcements
August 24, 2012
Current CDC recommendations focus on testing individuals with known hepatitis C risk factors. However, more than 75% of American adults with hepatitis C are baby boomers and baby boomers are five times more likely than adults of other ages to be infected. Likely reasons for this disproportionate infection rate are that this generation may have received blood transfusions before screening of the blood supply began 20 years ago and because they came of age before HIV brought awareness of the risks of unprotected sex and needle sharing.
ASRM Bulletins
August 13, 2012
Today, the Centers for Disease Control and Prevention (CDC) released updated guidelines for the treatment of the sexually transmitted disease gonorrhea in response to significant increases in documented cases throughout the US to the resistance of antibiotics in treating the disease.
ASRM Bulletins
July 20, 2012
Today, the U.S. Food and Drug Administration approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. Truvada, taken daily, is to be used for pre-exposure prophylaxis (PrEP) in combination with safer sex practices to reduce the risk of sexually-acquired HIV infection in adults at high risk.